Views & Analysis | Perspectives on pharma industry issues

R&D

Auto vacuum sealed vaccines in manufacturing plant

Reliability in life sciences logistics: What good looks like

What constitutes a reliable supply chain is changing rapidly.

Oncology

How AI is advancing patient subgroup identification in oncol...

With the advent of AI, it’s now possible to enrich clinical trials for patient subgroups more precisely than ever before.

Oncology

Personal reflections on World ADC, San Diego

At World ADC this month, the latest advances in ADC discovery and development were presented, debated, and reflected upon.

Oncology

ESMO26: Taiho Oncology on improving the lives of patients wi...

Dr Harold Keer, chief medical officer at Taiho Oncology, discusses the Phase 2 REZILIENT2 trial data presented at ESMO26 and the NSCLC setting.

R&D

Cardiovascular disease today: NMR-based lipoprotein profilin...

pharmaphorum spoke with Andreas Wolf, chief technology officer at numares Health about NMR-based lipoprotein profiling and cardiovascular disease.

Articles

mHealth Monthly Mashup: release 16.0 – what “responsive desi...

This month’s mashup takes a look at the latest trend in mobile technology, and considers implications for pharma… Technologists, despite their almost religious faith in transcendent reason and geeky cleverness, are hardly immune to irrational…

Articles

How can pharmaceutical companies engage with patients? Lesso...

Eileen O’Brien shares her thoughts on how pharma marketers can build better relationships with patients, looking at the lessons pharma can learn from rare disease brands. If information is power, then the Internet and social media have enabled a huge power shift in healthcare into...

Articles

The Pharma Marketing Show Europe 2012: event overview

Rebecca Aris provides an overview of day one at the ‘Pharma Marketing Show Europe 2012’ event as pharmaphorum’s marketing excellence month commences. The recent ‘Pharma Marketing Show Europe 2012’ event, held by health network communication in London was aimed at...

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

A sponsored video interview with Axria's Jeff Kaminski

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital